Related Experiment Video
Updated: Jan 26, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Randomized studies assessing the effect of flavor on pharmacokinetic and subjective parameters for dry and moist
Mikael Staaf1, Anna E Masser1, Camilla Pramfalk1
1Regulatory & Scientific Affairs, Swedish Match North Europe AB, Box 17037, Stockholm SE-104 62, Sweden.
Background:
Nicotine pouches (NPs) have different formulations (e.g., dry or moist), and the vast majority are flavored. However, it is unclear if flavors exert any effect on nicotine pharmacology and subjective parameters.
Methods:
Data from two, open-label, randomized, nine-way cross-over, single-dose administration, pharmacokinetic and subjective effects studies were analyzed, evaluating dry 6-mg and moist 9-mg NPs, respectively. The studies included unflavored and flavored varieties (flavor characteristics: traditional [tobacco], cooling, minty, fruit, beverage). All participants were adults who currently used snus and/or NPs daily (n = 38 for moist, n = 39 for dry).
Results:
Maximum plasma concentrations (Cmax) of nicotine were observed at NP removal at ~60min (Tmax), with overlapping geometric least squares mean (GLSM) values for the dry and moist products (12.08-15.07ng/mL). The total nicotine exposure (calculated as area under the curve from time point 0 to infinity, AUCinf) was 40.84-50.86h⁎ng/mL, with overlapping GLSM values for dry and moist varieties. Equivalence testing for AUCinf and Cmax between unflavored and flavored varieties showed equivalence for all varieties except two of the moist minty NPs. For subjective parameters, the effect of flavor was more pronounced for moist NPs, with participants rating the flavored varieties higher for satisfaction, product liking, and intent to use again.
Conclusions:
For dry varieties, flavor had no effect on Cmax and AUCinf, but two moist varieties were different from moist unflavored. Flavor did not affect Tmax for dry or moist NPs. Considerable variation in participant preferences suggest a need for diverse varieties and product types.
Related Concept Videos
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Dosage Regimens: Partial Pharmacokinetic Parameters
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

